Meloxicam
Who holds supplier records for Meloxicam? 19 organisations hold a current record for Meloxicam: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), Italy (3), Spain (2) and China (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Meloxicam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/meloxicam
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
11 of the 17 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Meloxicam expires 19 Jul 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Meloxicam. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Apex Healthcare LimitedIndiaCEPActive DMF 39911 · latest filing May 2024
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 18921 · latest filing Oct 2005
- ARCH PHARMALABS LTDIndiaCEPActive DMF 15926 · latest filing Apr 2002
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 17148 · latest filing Feb 2004
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 37567 · latest filing Nov 2022
- SWATI SPENTOSE PRIVATE LTDIndiaCEPActive DMF 18837 · latest filing Sept 2005
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 16189 · latest filing Oct 2002
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 17358 · latest filing May 2004
- AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPAItalyActive DMF 17238 · latest filing Mar 2004
- BIDACHEM SPAItaly Company GMP cert on recordActive DMF 13846 · latest filing Oct 1998
- DERIVADOS QUIMICOS SAUSpain Company GMP cert on recordActive DMF 24205 · latest filing Sept 2010
- QUIMICA SINTETICA SASpain Company GMP cert on recordActive DMF 18984 · latest filing Nov 2005
- SHANDONG XINHUA PHARMACEUTICAL CO LTDChina Company GMP cert on recordActive DMF 24476 · latest filing Dec 2010
- UNIMARK REMEDIES LTDIndiaActive DMF 18286 · latest filing Apr 2005
- ItalyCEP
- ESTEVE QUIMICA SACEP Company GMP cert on recordInactive DMF 16686 · latest filing Jul 2003
- IndiaCEP Company GMP cert on record
- NORBROOK LABORATORIES LTDCEP
- IndiaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (13)
Certificates of Suitability on the EDQM register for Meloxicam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2019-017 - Rev 04 Meloxicam | May 2026 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2009-184 - Rev 02 Meloxicam | Mar 2026 | — |
| ARCH PHARMALABS LIMITED Mumbai | IN | CEP 2019-283 - Rev 03 Meloxicam | Feb 2025 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2009-039 - Rev 02 Meloxicam | Nov 2024 | — |
| SWATI SPENTOSE PVT. LTD. Mumbai | IN | CEP 2014-261 - Rev 02 Meloxicam | Sept 2024 | — |
| AMSA S.P.A. - ANONIMA MATERIE SINTETICHE & AFFINI Como | IT | CEP 2022-430 - Rev 00 Meloxicam | Aug 2024 | Inspected May 2025 Italy |
| ESTEVE QUIMICA S.A. Barcelona | ES | CEP 2011-037 - Rev 02 Meloxicam, Powder and milled grade | Jan 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2008-061 - Rev 03 Meloxicam | Nov 2023 | — |
| IPCA Laboratories Limited Mumbai | IN | R0-CEP 2022-091 - Rev 01 Meloxicam, MX2 process | Jul 2023 | — |
| APEX HEALTHCARE LIMITED Ankleshwar | IN | R1-CEP 2016-061 - Rev 00 Meloxicam | May 2023 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2009-040 - Rev 05 Meloxicam, Micronised | Nov 2022 | — |
| MICRO LABS LIMITED Bengaluru | IN | R1-CEP 2012-077 - Rev 01 Meloxicam | Oct 2019 | — |
| NORBROOK LABORATORIES LIMITED Newry | IE | R1-CEP 2011-161 - Rev 01 Meloxicam | Aug 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Meloxicam are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- Micro Labs Ltd IndiaInactive DMF 25785 · filed Jan 2012
- SICHUAN SANCHINE SUNNYHOPE PHARMACEUTICAL CO LTDInactive DMF 21948 · filed Sept 2008
- India · Inactive DMF 19216 · filed Jan 2006
- Spain · Inactive DMF 18255 · filed Apr 2005
- India · Inactive DMF 17366 · filed May 2004
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (31 listed products contain Meloxicam). The latest listed patent expires 19 Jul 2040. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It works by inhibiting the synthesis of prostaglandins, which play a key role in inflammation.
Chemical identity
- IUPAC name
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide
- Canonical SMILES
- CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O
- InChIKey
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N
- Synonyms
- Mobic API, acticam, anjeso, contacera, coxicam, emdocam, flexicam, inflacam, loxicom, melfax, melosus, melovem
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
- Mechanism of action
- Cyclooxygenase Inhibitors
- Chemical structure
- Non-Steroidal
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Meloxicam?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Meloxicam: Apex Healthcare Limited (India), APITORIA PHARMA PRIVATE LTD (India), ARCH PHARMALABS LTD (India), Cipla Limited (India), Ipca Laboratories Limited (India), SWATI SPENTOSE PRIVATE LTD (India), Unichem Laboratories Ltd. (India) and Zydus Lifesciences Limited (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Meloxicam Drug Master Files are active?
Apex Healthcare Limited (DMF 39911), APITORIA PHARMA PRIVATE LTD (DMF 18921), ARCH PHARMALABS LTD (DMF 15926), Cipla Limited (DMF 17148), Ipca Laboratories Limited (DMF 37567), SWATI SPENTOSE PRIVATE LTD (DMF 18837), Unichem Laboratories Ltd. (DMF 16189) and Zydus Lifesciences Limited (DMF 17358) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Meloxicam records mean?
5 organisations have only inactive Type II DMFs for Meloxicam. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Meloxicam have a European Certificate of Suitability?
Yes. 13 organisations hold a valid CEP for Meloxicam on the EDQM register, including ZYDUS LIFESCIENCES LIMITED Vadodara (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), ARCH PHARMALABS LIMITED Mumbai (IN), UNICHEM LABORATORIES LIMITED Mumbai (IN), SWATI SPENTOSE PVT. LTD. Mumbai (IN) and AMSA S.P.A. - ANONIMA MATERIE SINTETICHE & AFFINI Como (IT) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Meloxicam?
Yes. The latest patent listed for an approved US product containing Meloxicam expires 19 Jul 2040, across 31 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Meloxicam supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Meloxicam?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.